EUVIMEDEUVIMED entdecken
Open Access

Aclarubicin stimulates RNA polymerase II elongation at closely spaced divergent promoters

Matthew Wooten iD, Brittany Takushi, Kami Ahmad iD, Steven Henikoff iD

Science Advances · 16.06.2023 · 9 (24)

DOI: 10.1126/sciadv.adg3257 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Science Advances, erschienen am 16.06.2023. Verfasst von Matthew Wooten und 3 weiteren Autor:innen. Beteiligte Einrichtung: Fred Hutchinson Cancer Center, Seattle, WA 98109, USA. Hauptthemen laut MEDLINE: Aclarubicin, Polyketides. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 94 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHGRI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Anthracyclines are a class of widely prescribed anticancer drugs that disrupt chromatin by intercalating into DNA and enhancing nucleosome turnover. To understand the molecular consequences of anthracycline-mediated chromatin disruption, we used Cleavage Under Targets and Tagmentation (CUT&Tag) to profile RNA polymerase II during anthracycline treatment in Drosophila cells. We observed that treatment with the anthracycline aclarubicin leads to elevated levels of RNA polymerase II and changes in chromatin accessibility. We found that promoter proximity and orientation affect chromatin changes during aclarubicin treatment, as closely spaced divergent promoter pairs show greater chromatin changes when compared to codirectionally oriented tandem promoters. We also found that aclarubicin treatment changes the distribution of noncanonical DNA G-quadruplex structures both at promoters and at G-rich pericentromeric repeats. Our work suggests that the cancer-killing activity of aclarubicin is driven by the disruption of nucleosomes and RNA polymerase II.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AclarubicinPolyketidesAnimalsRNA Polymerase IIAnthracyclinesChromatinNucleosomesDrosophila

Substanzen

aclacinomycinsAclarubicinRNA Polymerase IIAnthracyclinesChromatinNucleosomesPolyketides

Autor:innen und Institutionen

  • Fred Hutchinson Cancer Center, Seattle, WA 98109, USA.
  • Howard Hughes Medical Institute, Chevy Chase, MD 20815, USA.

ORCID-Profile: Matthew Wooten, Kami Ahmad, Steven Henikoff

Förderung

  • NHGRI NIH HHS

Zitieren

APA

Wooten, M., Takushi, B., Ahmad, K., & Henikoff, S. (2023). Aclarubicin stimulates RNA polymerase II elongation at closely spaced divergent promoters. Science Advances, 9(24). https://doi.org/10.1126/sciadv.adg3257

Vancouver

Wooten M, Takushi B, Ahmad K, Henikoff S. Aclarubicin stimulates RNA polymerase II elongation at closely spaced divergent promoters. Science Advances. 2023;9(24). doi:10.1126/sciadv.adg3257

BibTeX
@article{Wooten2023,
  author = {Wooten, Matthew and Takushi, Brittany and Ahmad, Kami and Henikoff, Steven},
  title = {Aclarubicin stimulates RNA polymerase II elongation at closely spaced divergent promoters},
  journal = {Science Advances},
  year = {2023},
  volume = {9},
  number = {24},
  doi = {10.1126/sciadv.adg3257}
}
Kostenlos starten →